Chronic disease risk among adults with cerebral palsy: The role of premature sarcopoenia, obesity and sedentary behaviour

Obesity Reviews

Volumn 14, Issue 2, 2013, Pages 171-182

  Peterson, M D ^a   Gordon, P M ^a   Hurvitz, E A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adiposity; Cerebral palsy; Motor disability; Sedentary behaviour

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGING; ARTICLE; BODY FAT; BODY MASS; CARDIOMETABOLIC RISK; CEREBRAL PALSY; CHRONIC DISEASE; DISABILITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY EXPENDITURE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; IMMOBILIZATION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MUSCLE ATROPHY; MUSCLE GROWTH; MUSCLE MASS; MUSCLE STRENGTH; NERVOUS SYSTEM INFLAMMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PHYSICAL ACTIVITY; RISK ASSESSMENT; SEDENTARY LIFESTYLE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WAIST TO HEIGHT RATIO;

ADULT; AGING; CEREBRAL PALSY; CHRONIC DISEASE; HUMANS; OBESITY; RISK FACTORS; SARCOPENIA; SEDENTARY LIFESTYLE; SEVERITY OF ILLNESS INDEX;

EID: 84872169170     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2012.01052.x     Document Type: Article

References (135)

1. Yeargin-Allsopp M, Van Naarden Braun K, Doernberg NS etal. Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration. Pediatrics 2008; 121: 547-554.
2. Kirby RS, Wingate MS, Van Naarden Braun K etal. Prevalence and functioning of children with cerebral palsy in four areas of the United States in 2006: a report from the Autism and Developmental Disabilities Monitoring Network. Res Dev Disabil 2011; 32: 462-469.
3. Paneth N, Hong T, Korzeniewski S. The descriptive epidemiology of cerebral palsy. Clin Perinatol 2006; 33: 251-267.
4. Murphy K, Molnar G, Lankasky K. Employment and social issues in adults with cerebral palsy. Arch Phys Med Rehabil 2000; 81: 807-811.
5. Day SM, Wu YW, Strauss DJ, Shavelle RM, Reynolds RJ. Change in ambulatory ability of adolescents and young adults with cerebral palsy. Dev Med Child Neurol 2007; 49: 647-653.
6. Bottos M, Feliciangeli A, Sciuto L, Gericke C, Vianello A. Functional status of adults with cerebral palsy and implications for treatment of children. Dev Med Child Neurol 2001; 43: 516-528.
7. Dunstan DW, Owen N. New exercise prescription: don't just sit there: stand up and move more, more often: comment on 'sitting time and all-cause mortality risk in 222, 497 Australian adults'. Arch Intern Med 2012; 172: 500-501.
8. Ando N, Ueda S. Functional deterioration in adults with cerebral palsy. Clin Rehabil 2000; 14: 300-306.
9. Opheim A, Jahnsen R, Olsson E, Stanghelle JK. Walking function, pain, and fatigue in adults with cerebral palsy: a 7 year follow-up study. Dev Med Child Neurol 2009; 51: 381-388.
10. Turk MA. Health, mortality, and wellness issues in adults with cerebral palsy. Dev Med Child Neurol 2009; 51 (Suppl. 4): 24-29.
11. Turk MA, Geremski CA, Rosenbaum PF, Weber RJ. The health status of women with cerebral palsy. Arch Phys Med Rehabil 1997; 78 (Suppl.): S10-17.
12. Schwartz L, Engel JM, Jensen MP. Pain in persons with cerebral palsy. Arch Phys Med Rehabil 1999; 80: 1243-1246.
13. Hirsh AT, Gallegos JC, Gertz KJ, Engel JM, Jensen MP. Symptom burden in individuals with cerebral palsy. J Rehabil Res Dev 2010; 47: 863-876.
14. Jahnsen R, Villien L, Aamodt G, Stanghelle J, Holm I. Musculoskeletal pain in adults with cerebral palsy compared with the general population. J Rehabil Med 2004; 2: 78-84.
15. Heller T, Ying Gs G, Rimmer J, Marks B. Determinants of exercise in adults with cerbral palsy. Public Heatlh Nurs 2002; 19: 223-231.
16. Lampe R, Grassl S, Mitternacht J, Gerdesmeyer L, Gradinger R. MRT-measurements of muscle volumes of the lower extremities of youths with spastic hemiplegia caused by cerebral palsy. Brain Dev 2006; 28: 500-506.
17. Shortland A. Muscle deficits in cerebral palsy and early loss of mobility: can we learn something from our elders? Dev Med Child Neurol 2009; 51 (Suppl. 4): 59-63.
18. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr 1997; 127 (Suppl.): 990S-991S.
19. Pendergast DR, Fisher NM, Calkins E. Cardiovascular, neuromuscular, and metabolic alterations with age leading to frailty. J Gerontol 1993; 48 (Spec No): 61-67.
20. Rantanen T, Guralnik JM, Foley D etal. Midlife hand grip strength as a predictor of old age disability. JAMA 1999; 281: 558-560.
21. Rantanen T, Guralnik JM, Sakari-Rantala R etal. Disability, physical activity, and muscle strength in older women: the Women's Health and Aging Study. Arch Phys Med Rehabil 1999; 80: 130-135.
22. Baumgartner RN, Koehler KM, Gallagher D etal. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755-763.
23. Rose J, McGill KC. Neuromuscular activation and motor-unit firing characteristics in cerebral palsy. Dev Med Child Neurol 2005; 47: 329-336.
24. Stackhouse SK, Binder-Macleod SA, Lee SC. Voluntary muscle activation, contractile properties, and fatigability in children with and without cerebral palsy. Muscle Nerve 2005; 31: 594-601.
25. Kurz MJ, Stuberg WA, DeJong SL. Mechanical work performed by the legs of children with spastic diplegic cerebral palsy. Gait Posture 2010; 31: 347-350.
26. Piccinini L, Cimolin V, Galli M etal. Quantification of energy expenditure during gait in children affected by cerebral palsy. Eura Medicophys 2007; 43: 7-12.
27. Unnithan VB, Dowling JJ, Frost G, Bar-Or O. Role of cocontraction in the O2 cost of walking in children with cerebral palsy. Med Sci Sports Exerc 1996; 28: 1498-1504.
28. Maltais DB, Pierrynowski MR, Galea VA, Bar-Or O. Physical activity level is associated with the O2 cost of walking in cerebral palsy. Med Sci Sports Exerc 2005; 37: 347-353.
29. Maltais DB, Pierrynowski MR, Galea VA, Matsuzaka A, Bar-Or O. Habitual physical activity levels are associated with biomechanical walking economy in children with cerebral palsy. Am J Phys Med Rehabil 2005; 84: 36-45.
30. Jahnsen R, Villien L, Aamodt G, Stanghelle JK, Holm I. Musculoskeletal pain in adults with cerebral palsy compared with the general population. J Rehabil Med 2004; 36: 78-84.
31. Murphy KP, Molnar GE, Lankasky K. Medical and functional status of adults with cerebral palsy. Dev Med Child Neurol 1995; 37: 1075-1084.
32. Tosi LL, Maher N, Moore DW, Goldstein M, Aisen ML. Adults with cerebral palsy: a workshop to define the challenges of treating and preventing secondary musculoskeletal and neuromuscular complications in this rapidly growing population. Dev Med Child Neurol 2009; 51 (Suppl. 4): 2-11.
33. Kuk JL, Katzmarzyk PT, Nichaman MZ etal. Visceral fat is an independent predictor of all-cause mortality in men. Obesity (Silver Spring) 2006; 14: 336-341.
34. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-887.
35. Rogozinski BM, Davids JR, Davis RB etal. Prevalence of obesity in ambulatory children with cerebral palsy. J Bone Joint Surg Am 2007; 89: 2421-2426.
36. Hurvitz EA, Green LB, Hornyak JE, Khurana SR, Koch LG. Body mass index measures in children with cerebral palsy related to gross motor function classification: a clinic-based study. Am J Phys Med Rehabil 2008; 87: 395-403.
37. van den Berg-Emons RJ, van Baak MA, Westerterp KR. Are skinfold measurements suitable to compare body fat between children with spastic cerebral palsy and healthy controls? Dev Med Child Neurol 1998; 40: 335-339.
38. Hildreth HG, Johnson RK, Goran MI, Contompasis SH. Body composition in adults with cerebral palsy by dual-energy X-ray absorptiometry, bioelectrical impedance analysis, and skinfold anthropometry compared with the 18O isotope-dilution technique. Am J Clin Nutr 1997; 66: 1436-1442.
39. Rimmer JH, Braddock D, Pitetti KH. Research on physical activity and disability: an emerging national priority. Med Sci Sports Exerc 1996; 28: 1366-1372.
40. Bauman WA. The potential metabolic consequences of cerebral palsy: inferences from the general population and persons with spinal cord injury. Dev Med Child Neurol 2009; 51 (Suppl. 4): 64-78.
41. Bauman WA, Spungen AM. Disorders of carbohydrate and lipid metabolism in veterans with paraplegia or quadriplegia: a model of premature aging. Metabolism 1994; 43: 749-756.
42. Rimmer JH, Yamaki K, Lowry BM, Wang E, Vogel LC. Obesity and obesity-related secondary conditions in adolescents with intellectual/developmental disabilities. J Intellect Disabil Res 2010; 54: 787-794.
43. Strauss D, Cable W, Shavelle R. Causes of excess mortality in cerebral palsy. Dev Med Child Neurol 1999; 41: 580-585.
44. Maher CA, Williams MT, Olds T, Lane AE. Physical and sedentary activity in adolescents with cerebral palsy. Dev Med Child Neurol 2007; 49: 450-457.
45. Bjornson KF, Belza B, Kartin D, Logsdon R, McLaughlin JF. Ambulatory physical activity performance in youth with cerebral palsy and youth who are developing typically. Phys Ther 2007; 87: 248-257.
46. Okorodudu DO, Jumean MF, Montori VM etal. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond) 2010; 34: 791-799.
47. Arrowsmith FE, Allen JR, Gaskin KJ etal. Reduced body protein in children with spastic quadriplegic cerebral palsy. Am J Clin Nutr 2006; 83: 613-618.
48. Elder GC, Kirk J, Stewart G etal. Contributing factors to muscle weakness in children with cerebral palsy. Dev Med Child Neurol 2003; 45: 542-550.
49. Sheridan KJ. Osteoporosis in adults with cerebral palsy. Dev Med Child Neurol 2009; 51 (Suppl. 4): 38-51.
50. Gajdosik CG, Cicirello N. Secondary conditions of the musculoskeletal system in adolescents and adults with cerebral palsy. Phys Occup Ther Pediatr 2001; 21: 49-68.
51. Romero-Corral A, Somers VK, Sierra-Johnson J etal. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 2010; 31: 737-746.
52. Peterson MD, Haapala HJ, Hurvitz EA. Predictors of cardiometabolic risk among adults with cerebral palsy. Arch Phys Med Rehabil 2012; 93: 816-821.
53. Yusuf S, Hawken S, Ounpuu S etal. Obesity and the risk of myocardial infarction in 27, 000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649.
54. Pischon T, Boeing H, Hoffmann K etal. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105-2120.
55. Nishida C, Ko GT, Kumanyika S. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr 2010; 64: 2-5.
56. Delmonico MJ, Harris TB, Visser M etal. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 2009; 90: 1579-1585.
57. Goodpaster BH, Carlson CL, Visser M etal. Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study. J Appl Physiol 2001; 90: 2157-2165.
58. Goodpaster BH, Thaete FL, Kelley DE. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr 2000; 71: 885-892.
59. Visser M, Goodpaster BH, Kritchevsky SB etal. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci 2005; 60: 324-333.
60. Rodeheffer MS. Tipping the scale: muscle versus fat. Nat Cell Biol 2010; 12: 102-104.
61. Goodpaster BH, Park SW, Harris TB etal. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006; 61: 1059-1064.
62. Jubrias SA, Odderson IR, Esselman PC, Conley KE. Decline in isokinetic force with age: muscle cross-sectional area and specific force. Pflugers Arch 1997; 434: 246-253.
63. Overend TJ, Cunningham DA, Kramer JF, Lefcoe MS, Paterson DH. Knee extensor and knee flexor strength: cross-sectional area ratios in young and elderly men. J Gerontol 1992; 47: M204-M210.
64. Cruz-Jentoft AJ, Baeyens JP, Bauer JM etal. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-423.
65. Ruiz JR, Sui X, Lobelo F etal. Association between muscular strength and mortality in men: prospective cohort study. BMJ 2008; 337: a439.
66. Pijnappels M, Reeves ND, Maganaris CN, van Dieen JH. Tripping without falling; lower limb strength, a limitation for balance recovery and a target for training in the elderly. J Electromyogr Kinesiol 2008; 18: 188-196.
67. Schrager MA, Metter EJ, Simonsick E etal. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 2007; 102: 919-925.
68. Lim S, Kim JH, Yoon JW etal. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 2010; 33: 1652-1654.
69. Stenholm S, Harris TB, Rantanen T etal. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 2008; 11: 693-700.
70. Hilton TN, Tuttle LJ, Bohnert KL, Mueller MJ, Sinacore DR. Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function. Phys Ther 2008; 88: 1336-1344.
71. Walter S, Kunst A, Mackenbach J, Hofman A, Tiemeier H. Mortality and disability: the effect of overweight and obesity. Int J Obes (Lond) 2009; 33: 1410-1418.
72. Ferraro KF, Su YP, Gretebeck RJ, Black DR, Badylak SF. Body mass index and disability in adulthood: a 20-year panel study. Am J Public Health 2002; 92: 834-840.
73. Hulens M, Vansant G, Lysens R etal. Study of differences in peripheral muscle strength of lean versus obese women: an allometric approach. Int J Obes Relat Metab Disord 2001; 25: 676-681.
74. Schrauwen P, Schrauwen-Hinderling V, Hoeks J, Hesselink MK. Mitochondrial dysfunction and lipotoxicity. Biochim Biophys Acta 2010; 1801: 266-271.
75. Kewalramani G, Bilan PJ, Klip A. Muscle insulin resistance: assault by lipids, cytokines and local macrophages. Curr Opin Clin Nutr Metab Care 2010; 13: 382-390.
76. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002; 51: 2005-2011.
77. Lara-Castro C, Garvey WT. Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome. Endocrinol Metab Clin North Am 2008; 37: 841-856.
78. Goodpaster BH, Kelley DE, Thaete FL, He J, Ross R. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol 2000; 89: 104-110.
79. Vettor R, Milan G, Franzin C etal. The origin of intermuscular adipose tissue and its pathophysiological implications. Am J Physiol Endocrinol Metab 2009; 297: E987-E998.
80. Rossi A, Zoico E, Goodpaster BH etal. Quantification of intermuscular adipose tissue in the erector spinae muscle by MRI: agreement with histological evaluation. Obesity (Silver Spring) 2010; 18: 2379-2384.
81. Leroy-Willig A, Willig TN, Henry-Feugeas MC etal. Body composition determined with MR in patients with Duchenne muscular dystrophy, spinal muscular atrophy, and normal subjects. Magn Reson Imaging 1997; 15: 737-744.
82. Gallagher D, Kelley DE, Yim JE etal. Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr 2009; 89: 807-814.
83. Gorgey AS, Dudley GA. Skeletal muscle atrophy and increased intramuscular fat after incomplete spinal cord injury. Spinal Cord 2007; 45: 304-309.
84. Shah PK, Gregory CM, Stevens JE etal. Non-invasive assessment of lower extremity muscle composition after incomplete spinal cord injury. Spinal Cord 2008; 46: 565-570.
85. Greco AV, Mingrone G, Giancaterini A etal. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002; 51: 144-151.
86. Kelley DE, Slasky BS, Janosky J. Skeletal muscle density: effects of obesity and non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1991; 54: 509-515.
87. Simoneau JA, Colberg SR, Thaete FL, Kelley DE. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J 1995; 9: 273-278.
88. Manini TM, Clark BC, Nalls MA etal. Reduced physical activity increases intermuscular adipose tissue in healthy young adults. Am J Clin Nutr 2007; 85: 377-384.
89. Beasley LE, Koster A, Newman AB etal. Inflammation and race and gender differences in computerized tomography-measured adipose depots. Obesity (Silver Spring) 2009; 17: 1062-1069.
90. Zoico E, Rossi A, Di Francesco V etal. Adipose tissue infiltration in skeletal muscle of healthy elderly men: relationships with body composition, insulin resistance, and inflammation at the systemic and tissue level. J Gerontol A Biol Sci Med Sci 2010; 65: 295-299.
91. Visser M, Pahor M, Taaffe DR etal. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 2002; 57: M326-M332.
92. Schrauwen-Hinderling VB, Kooi ME, Hesselink MK etal. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 2007; 50: 113-120.
93. Phielix E, Schrauwen-Hinderling VB, Mensink M etal. Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 2008; 57: 2943-2949.
94. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350: 664-671.
95. Perseghin G, Scifo P, De Cobelli F etal. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999; 48: 1600-1606.
96. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 2001; 86: 5755-5761.
97. Tarnopolsky MA, Rennie CD, Robertshaw HA etal. Influence of endurance exercise training and sex on intramyocellular lipid and mitochondrial ultrastructure, substrate use, and mitochondrial enzyme activity. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1271-R1278.
98. Dube JJ, Amati F, Stefanovic-Racic M etal. Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited. Am J Physiol Endocrinol Metab 2008; 294: E882-E888.
99. Chomentowski P, Coen PM, Radikova Z, Goodpaster BH, Toledo FG. Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility. J Clin Endocrinol Metab 2011; 96: 494-503.
100. Crane JD, Devries MC, Safdar A, Hamadeh MJ, Tarnopolsky MA. The effect of aging on human skeletal muscle mitochondrial and intramyocellular lipid ultrastructure. J Gerontol A Biol Sci Med Sci 2010; 65: 119-128.
101. Johnson DL, Miller F, Subramanian P, Modlesky CM. Adipose tissue infiltration of skeletal muscle in children with cerebral palsy. J Pediatr 2009; 154: 715-720.
102. Fernandez JE, Pitetti KH. Training of ambulatory individuals with cerebral palsy. Arch Phys Med Rehabil 1993; 74: 468-472.
103. Fleiss B, Gressens P. Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy? Lancet Neurol 2012; 11: 556-566.
104. Rezaie P, Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 2002; 22: 106-132.
105. Khwaja O, Volpe JJ. Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed 2008; 93: F153-F161.
106. Peterson MD, Hurvitz EA, Burant CF. Secondary muscle pathology and metabolic dysregulation in adults with cerebral palsy. Am J Physiol Endocrinol Metab 2012. doi: 10.1152/ajpendo.00338.2012.
107. Lin CY, Chang YC, Wang ST etal. Altered inflammatory responses in preterm children with cerebral palsy. Ann Neurol 2010; 68: 204-212.
108. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011; 121: 2111-2117.
109. Thaler JP, Schwartz MW. Minireview: inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology 2010; 151: 4109-4115.
110. Kerr Graham H, Selber P. Musculoskeletal aspects of cerebral palsy. J Bone Joint Surg Br 2003; 85: 157-166.
111. Fielding RA, Vellas B, Evans WJ etal. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12: 249-256.
112. Bauer JM, Sieber CC. Sarcopenia and frailty: a clinician's controversial point of view. Exp Gerontol 2008; 43: 674-678.
113. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 50: 889-896.
114. Balboa-Castillo T, Guallar-Castillon P, Leon-Munoz LM etal. Physical activity and mortality related to obesity and functional status in older adults in Spain. Am J Prev Med 2011; 40: 39-46.
115. Andersson C, Grooten W, Hellsten M, Kaping K, Mattsson E. Adults with cerebral palsy: walking ability after progressive strength training. Dev Med Child Neurol 2003; 45: 220-228.
116. Verschuren O, Wiart L, Hermans D, Ketelaar M. Identification of facilitators and barriers to physical activity in children and adolescents with cerebral palsy. J Pediatr 2012; 161: 488-494.
117. Rimmer JH. Physical fitness levels of persons with cerebral palsy. Dev Med Child Neurol 2001; 43: 208-212.
118. Capio C, Sit CH, Abernethy B, Masters RS. Fundamental movement skills and physical activity among children with and without cerebral palsy. Res Dev Disabil 2012; 33: 1235-1241.
119. Chastin SF, Ferriolli E, Stephens NA, Fearon KC, Greig C. Relationship between sedentary behaviour, physical activity, muscle quality and body composition in healthy older adults. Age Ageing 2011; 41: 111-114.
120. Katzmarzyk PT, Church TS, Craig CL, Bouchard C. Sitting time and mortality from all causes, cardiovascular disease, and cancer. Med Sci Sports Exerc 2009; 41: 998-1005.
121. Hamilton MT, Hamilton DG, Zderic TW. Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 2007; 56: 2655-2667.
122. Kortebein P, Symons TB, Ferrando A etal. Functional impact of 10 days of bed rest in healthy older adults. J Gerontol A Biol Sci Med Sci 2008; 63: 1076-1081.
123. Healy GN, Dunstan DW, Salmon J etal. Television time and continuous metabolic risk in physically active adults. Med Sci Sports Exerc 2008; 40: 639-645.
124. Sedentary Behaviour Research Network. Letter to the editor: standardized use of the terms 'sedentary' and 'sedentary behaviours'. Appl Physiol Nutr Metab 2012; 37: 540-545.
125. Cesari M, Pahor M, Lauretani F etal. Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci 2009; 64: 377-384.
126. Gardiner PA, Healy GN, Eakin EG etal. Associations between television viewing time and overall sitting time with the metabolic syndrome in older men and women: the Australian Diabetes, Obesity and Lifestyle study. J Am Geriatr Soc 2011; 59: 788-796.
127. DHHS. 2008 Physical Activity Guidelines for Americans. Rockville (MD): U.S. Department of Health and Human Services.; 2008.
128. Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA etal. American College of Sports Medicine position stand. Exercise and physical activity for older adults. Med Sci Sports Exerc 2009; 41: 1510-1530.
129. Nelson ME, Rejeski WJ, Blair SN etal. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116: 1094-1105.
130. Bouchard C, Blair SN, Haskell WL. Physical Activity and Health, 2nd edn. Human Kinetics: Champaign, IL, 2007.
131. Peterson MD, Lukasik L, Muth T, Esposito P, Hurvitz EA. The NuStep® is a feasible and safe mode of physical activity for significantly motor-impaired adults with cerebral palsy. Arch Phys Med Rehabil 2012; in press.
132. Lynch NA, Metter EJ, Lindle RS etal. Muscle quality. I. Age-associated differences between arm and leg muscle groups. J Appl Physiol 1999; 86: 188-194.
133. Young A, Stokes M, Crowe M. The size and strength of the quadriceps muscles of old and young men. Clin Physiol 1985; 5: 145-154.
134. Bassey EJ, Harries UJ. Normal values for handgrip strength in 920 men and women aged over 65 years, and longitudinal changes over 4 years in 620 survivors. Clin Sci (Lond) 1993; 84: 331-337.
135. Ferrucci L, Guralnik JM, Pahor M, Corti MC, Havlik RJ. Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA 1997; 277: 728-734.